TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20032493

Group type: EXPERIMENTAL
Intervention: Low-fat, high-carbohydrate diet (LF)
Number of subjects: 771

Group type: COMPARATOR
Intervention: High-fat, low-carbohydrate diet (HF)
Number of subjects: 771

Group type: EXPERIMENTAL
Intervention: High-fat diet (HF) for homozygous T-risk allele carriers
Number of subjects: 771

Group type: EXPERIMENTAL
Intervention: High-fat diet (HF)
Number of subjects: 771
Study: 18997650

Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg/kg)
Number of subjects: 10
Study: 15661598

Group type: EXPERIMENTAL
Intervention: TeenSTAR Program (abstinence-centered sex education program) applied to 210 students in the 1997 cohort
Number of subjects: 1259

Group type: EXPERIMENTAL
Intervention: TeenSTAR Program (abstinence-centered sex education program) applied to 328 students in the 1998 cohort
Number of subjects: 1259

Group type: COMPARATOR
Intervention: Control group (no intervention) in the 1997 cohort
Number of subjects: 1259

Group type: COMPARATOR
Intervention: Control group (no intervention) in the 1998 cohort
Number of subjects: 1259
Study: 11823078

Group type: EXPERIMENTAL
Intervention: Heparin (5,000 IU 10 min before exercise, followed by 1,000 IU/h)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Trimetazidine (20 mg) + Heparin (5,000 IU 10 min before exercise, followed by 1,000 IU/h)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Trimetazidine (20 mg) + Saline (10 ml 10 min before exercise)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo + Heparin (5,000 IU 10 min before exercise, followed by 1,000 IU/h)
Number of subjects: 9
Study: 10087725

Group type: EXPERIMENTAL
Intervention: Ondansetron (4 mg)
Number of subjects: 408

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 408
Study: 7677239

Group type: EXPERIMENTAL
Intervention: Breathing filter
Number of subjects: 9

Group type: COMPARATOR
Intervention: No breathing filter
Number of subjects: 9

Group type: COMPARATOR
Intervention: Two breathing filters connected in parallel
Number of subjects: 9
Study: 2188239

Group type: EXPERIMENTAL
Intervention: Permethrin 5% cream (Elimite)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Crotamiton 10% cream (Eurax)
Number of subjects: 94
Study: 6989683

Group type: EXPERIMENTAL
Intervention: Oral metoprolol
Number of subjects: 9

Group type: COMPARATOR
Intervention: Oral propranolol
Number of subjects: 9
Study: 31173179

Group type: EXPERIMENTAL
Intervention: Hypertensive patients
Number of subjects: 80

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 80
Study: 28986203

Group type: EXPERIMENTAL
Intervention: Nebulised inhaled unfractionated heparin (UFH) 150,000 IU BID for 21 days
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nebulised inhaled unfractionated heparin (UFH) 75,000 IU BID for 21 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 26853211

Group type: EXPERIMENTAL
Intervention: Indigenous Oral Health Literacy Project (IOHLP) participants
Number of subjects: 0

Group type: COMPARATOR
Intervention: National Survey of Adult Oral Health (NSAOH) participants
Number of subjects: 0
Study: 24731111

Group type: EXPERIMENTAL
Intervention: Individual brief motivational intervention (iBMI)
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Group brief motivational intervention (gBMI)
Number of subjects: 278
Study: 22594116

Group type: EXPERIMENTAL
Intervention: Surrounding acupuncture plus electric acupuncture (Group A)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Cotton‐sheet moxibustion (Group B)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Puncturing with red‐hot needles (Group C)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Tapping plus cupping (Group D)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Western medicine (Group E)
Number of subjects: 500
Study: 20171359

Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:100,000 epinephrine
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 4% articaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2% lidocaine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both articaine and lidocaine
Number of subjects: 40
Study: 18570129

Group type: EXPERIMENTAL
Intervention: Labor (no specific intervention mentioned)
Number of subjects: 301
Study: 15780173

Group type: EXPERIMENTAL
Intervention: docetaxel plus prednisone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: docetaxel plus estramustine
Number of subjects: 0

Group type: COMPARATOR
Intervention: mitoxantrone plus prednisone
Number of subjects: 0
Study: 14622078

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral analysis system of psychotherapy (CBASP)
Number of subjects: 347

Group type: COMPARATOR
Intervention: Nefazodone
Number of subjects: 347

Group type: COMPARATOR
Intervention: Combination therapy (Nefazodone + CBASP)
Number of subjects: 347
Study: 10777184

Group type: COMPARATOR
Intervention: EHC (extra-hepatic cholestasis)
Number of subjects: 80

Group type: COMPARATOR
Intervention: IHC (intrahepatic cholestasis)
Number of subjects: 80
Study: 8823020

Group type: EXPERIMENTAL
Intervention: 6‐0 polydioxanone
Number of subjects: 20

Group type: COMPARATOR
Intervention: 6‐0 polyglactin 910
Number of subjects: 20
Study: 1527133

Group type: EXPERIMENTAL
Intervention: A-V Impulse System
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82
Study: 3736141

Group type: EXPERIMENTAL
Intervention: Monthly feedback reports of compliance with preventive care protocols
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Specific reminders given at the time of patient visits
Number of subjects: 135

Group type: COMPARATOR
Intervention: Reminders alone
Number of subjects: 135

Group type: COMPARATOR
Intervention: Neither feedback nor reminders
Number of subjects: 135
Study: 31532824

Group type: EXPERIMENTAL
Intervention: Autogenous bone ring transplant (BR)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Autologous growth factor-enriched bone graft matrix (AFG)
Number of subjects: 34
Study: 29570467

Group type: EXPERIMENTAL
Intervention: Bedside respiratory muscle training (twice a day for 3 weeks) including breath stacking exercise, inspiratory muscle training, and expiratory muscle training.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional stroke rehabilitation program (control group).
Number of subjects: 40
Study: 26699603

Group type: EXPERIMENTAL
Intervention: BALANCE Program (prescribed diet, nutritional education strategy, intensive follow-up)
Number of subjects: 2468

Group type: COMPARATOR
Intervention: Generic advice on low-fat, low-energy, low-sodium, and low-cholesterol diet
Number of subjects: 2468
Study: 23975250

Group type: EXPERIMENTAL
Intervention: Bipolar hemiarthroplasty
Number of subjects: 222

Group type: COMPARATOR
Intervention: Internal fixation with two parallel screws
Number of subjects: 222
Study: 22709769

Group type: EXPERIMENTAL
Intervention: Intervention group (Work, Weight, and Wellness trial)
Number of subjects: 4236

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 4236

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 4236
Study: 21147707

Group type: EXPERIMENTAL
Intervention: Whey-predominant formula containing LCPUFAs and oligosaccharides (FOS/GOS)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control casein-predominant formula
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Breast-fed infants
Number of subjects: 144
Study: 18204158

Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New strategies to control inflammation in COPD
Number of subjects: 0
Study: 15716689

Group type: EXPERIMENTAL
Intervention: Bell side of the acoustic stethoscope
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Diaphragm side of the acoustic stethoscope
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Low-frequency amplification of systolic Korotkoff sounds
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: High-frequency amplification of systolic Korotkoff sounds
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Low-frequency amplification of diastolic Korotkoff sounds
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: High-frequency amplification of diastolic Korotkoff sounds
Number of subjects: 250
Study: 12222753

Group type: EXPERIMENTAL
Intervention: 500 mg of metformin with 500 mg of cephalexin
Number of subjects: 12

Group type: COMPARATOR
Intervention: 500 mg of metformin with placebo
Number of subjects: 12
Study: 10559616

Group type: EXPERIMENTAL
Intervention: Tamsulosin (0.4 mg modified release formulation once daily)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 355
Study: 8551449

Group type: EXPERIMENTAL
Intervention: Type A IOLs (convex-plano)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Type B IOLs (biconvex, anterior more curved)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Type D IOLs (biconvex, posterior more curved)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Type A, B, and C IOLs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Type D IOLs
Number of subjects: 0
Study: 2128029

Group type: EXPERIMENTAL
Intervention: Garlic (specific dosage and duration not mentioned)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 365009

Group type: EXPERIMENTAL
Intervention: Intravenous cephalothin combined with mechanical colon cleansing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison group (not specified, likely oral neomycin-erythromycin base and mechanical colon cleansing)
Number of subjects: 0
Study: 29886499

Group type: EXPERIMENTAL
Intervention: Preoperative enteral nutrition enriched with eicosapentaenoic acid (EPA) (600 kcal/day for 7 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Isocaloric isonitrogenous standard nutrition (600 kcal/day for 7 days)
Number of subjects: 20
Study: 28034693

Group type: EXPERIMENTAL
Intervention: Educational text message daily and instructive phone calls three days a week for three months along with usual care
Number of subjects: 66

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 66
Study: 26227279

Group type: EXPERIMENTAL
Intervention: Vaginal formulation (VF)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Reduced glycerin vaginal formulation (RGVF)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Isoosmolal rectal-specific formulation (RF)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Simulated unprotected receptive anal intercourse (RAI)
Number of subjects: 9
Study: 25005333

Group type: EXPERIMENTAL
Intervention: Calcium-vitamin D co-supplementation (50,000 U/week vitamin D + 1,000 mg/day calcium)
Number of subjects: 118
Study: 22390325

Group type: EXPERIMENTAL
Intervention: Eye patches (four main brands)
Number of subjects: 24
Study: 20533214

Group type: EXPERIMENTAL
Intervention: Vitamin C (250 mg every other day for 12 weeks)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 17804954

Group type: EXPERIMENTAL
Intervention: Interactive Voice Response (IVR) cognitive testing
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Telephonic Remote Evaluation of Neuropsychological Deficit tasks
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: IVR informant data
Number of subjects: 107
Study: 15080373

Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg daily) with or without indapamide (2 mg daily)
Number of subjects: 667

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 667
Study: 12190102

Group type: EXPERIMENTAL
Intervention: Flexible sigmoidoscopy (FS) screening examination
Number of subjects: 4956
Study: 9818624

Group type: EXPERIMENTAL
Intervention: Reboxetine (8-10 mg/day)
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20-40 mg/day)
Number of subjects: 549

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 549
Study: 7650634

Group type: EXPERIMENTAL
Intervention: Corporate values perceived importance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Corporate values related to occupational group, gender, age, and company size
Number of subjects: 0
Study: 2782470

Group type: EXPERIMENTAL
Intervention: Cognitive therapy plus standard treatment
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Social skills training plus standard treatment
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard treatment (hospital milieu therapy, pharmacotherapy, clinical management sessions)
Number of subjects: 45
Study: 7034157

Group type: EXPERIMENTAL
Intervention: Endoscopic YAG-laser treatment
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (active surgical approach)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Endoscopic YAG-laser treatment vs Control group
Number of subjects: 135
Study: 30864452

Group type: EXPERIMENTAL
Intervention: Younger children (6-9 years)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Adolescents (10-17 years)
Number of subjects: 2
Study: 28224296

Group type: EXPERIMENTAL
Intervention: SF-6D utility scores
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: EQ-5D-5L utility scores
Number of subjects: 294
Study: 25893652

Group type: EXPERIMENTAL
Intervention: 3D high-definition (HD) display
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2D HD imaging system
Number of subjects: 40
Study: 24061999

Group type: EXPERIMENTAL
Intervention: Erythromycin (0.25 g tid po for 1 week)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no erythromycin)
Number of subjects: 30
Study: 21861028

Group type: EXPERIMENTAL
Intervention: GT rotary instruments
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ProFile rotary instruments
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ProTaper rotary instruments
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: K3 rotary instruments
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hand K-files
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hero instruments
Number of subjects: 60
Study: 19652953

Group type: EXPERIMENTAL
Intervention: High PEEP (11.0 cmH2O) with high respiratory rate
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: High PEEP (11.0 cmH2O) with low respiratory rate
Number of subjects: 11

Group type: COMPARATOR
Intervention: Low PEEP (5.4 cmH2O)
Number of subjects: 11
Study: 18322814

Group type: EXPERIMENTAL
Intervention: MTHFR CT genotype
Number of subjects: 1603

Group type: COMPARATOR
Intervention: Total folate intake
Number of subjects: 1603
Study: 15208845

Group type: EXPERIMENTAL
Intervention: Postdiagnosis parent mentoring intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention during the 6-month trial)
Number of subjects: 0
Study: 11240078

Group type: EXPERIMENTAL
Intervention: Hypertonic saline infusion into the masseter muscle
Number of subjects: 10

Group type: COMPARATOR
Intervention: Isotonic saline infusion in the contralateral masseter (control)
Number of subjects: 10
Study: 9341430

Group type: EXPERIMENTAL
Intervention: Hydropolymer dressing (Tielle)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Hydrocolloid dressing (Granuflex)
Number of subjects: 199
Study: 8286300

Group type: EXPERIMENTAL
Intervention: Fluoride-containing composite cement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional adhesive (Concise)
Number of subjects: 0
Study: 3735482

Group type: EXPERIMENTAL
Intervention: NaHCO3 0.15 g per kg body weight
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: NaHCO3 0.30 g per kg body weight
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 11756618

Group type: EXPERIMENTAL
Intervention: Atraumatic Sprotte needle
Number of subjects: 230

Group type: COMPARATOR
Intervention: Traumatic Quincke needle
Number of subjects: 230
Study: 31427292

Group type: EXPERIMENTAL
Intervention: Piperacillin-tazobactam (TZP) 80 mg/kg every 6 h infused over 2 h for ages 2 to 5 months
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Piperacillin-tazobactam (TZP) 90 mg/kg every 8 h infused over 4 h for ages 6 months to 6 years
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Piperacillin-tazobactam (TZP) 75 mg/kg every 4 h infused over 0.5 h for infants ages 2 to <6 months
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Piperacillin-tazobactam (TZP) 130 mg/kg every 8 h infused over 4 h for children ages >6 months to 6 years
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Adverse events during treatment
Number of subjects: 79
Study: 28725956

Group type: EXPERIMENTAL
Intervention: Child‐ and Family‐Focused Cognitive‐Behavioral Therapy (CFF‐CBT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: NSSI presence
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: NSSI absence
Number of subjects: 72
Study: 27166709

Group type: EXPERIMENTAL
Intervention: Ajwain 10 % topical cream
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 25420431

Group type: EXPERIMENTAL
Intervention: Monsenso system including a feedback loop between patients and clinicians
Number of subjects: 0

Group type: COMPARATOR
Intervention: Smartphone for normal communicative purposes
Number of subjects: 0
Study: 22595063

Group type: EXPERIMENTAL
Intervention: Oxybutynin 0.6 mg/kg per day for 12 weeks
Number of subjects: 42
Study: 19793865

Group type: EXPERIMENTAL
Intervention: Treatment of latent TB infection (LTBI)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: 9-month isoniazid regimen
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Residence in a congregate setting (nursing home, shelter, or jail)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Injection drug use
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Age >or= 15 years
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Employment at a health-care facility
Number of subjects: 720
Study: 17277594

Group type: EXPERIMENTAL
Intervention: Creatine/Carbohydrate (CrCHO)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Creatine/Whey Protein (CrWP)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Whey Protein (WP)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Carbohydrate only (CHO)
Number of subjects: 4
Study: 16198216

Group type: EXPERIMENTAL
Intervention: Simple advice and educational booklet given to non-smoking pregnant women (intervention group)
Number of subjects: 758

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 758
Study: 12416945

Group type: COMPARATOR
Intervention: Cardioselective β-blocker (single dose)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Cardioselective β-blocker (continued treatment)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Cardioselective β-blocker (single dose) in patients with COPD
Number of subjects: 29

Group type: COMPARATOR
Intervention: Cardioselective β-blocker (continued treatment) in patients with COPD
Number of subjects: 29
Study: 10220232

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall costs for all agents except chlorthalidone
Number of subjects: 0
Study: 7752269

Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen (40 mg daily for 2 years)
Number of subjects: 2729
Study: 1973717

Group type: EXPERIMENTAL
Intervention: Surfactant treatment (Reconstituted bovine surfactant, 120 mg/kg body weight, delivered in 5 divided doses)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Air placebo (4 ml per kilogram)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Surfactant treatment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Air placebo
Number of subjects: 18
Study: 7191298

Group type: EXPERIMENTAL
Intervention: 80 mg oxprenolol twice a day
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 160 mg slow-release oxprenolol once a day
Number of subjects: 11
Study: 31227466

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided single-dose interscalene block (USG SDIB)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Balanced general anesthesia (BGA)
Number of subjects: 20
Study: 28961662

Group type: EXPERIMENTAL
Intervention: Citalopram monotherapy (DOCS group)
Number of subjects: 2280

Group type: EXPERIMENTAL
Intervention: Citalopram monotherapy (non-DOCS group)
Number of subjects: 2280

Group type: EXPERIMENTAL
Intervention: Remission from MDD (both groups)
Number of subjects: 2280
Study: 26505723

Group type: EXPERIMENTAL
Intervention: 0.9% normal saline
Number of subjects: 100

Group type: COMPARATOR
Intervention: 0.1% polyhexanide plus 0.1% betaine
Number of subjects: 100
Study: 23842022

Group type: EXPERIMENTAL
Intervention: Paliperidone (up to 9 mg/d)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Paliperidone
Number of subjects: 34
Study: 22544579

Group type: EXPERIMENTAL
Intervention: Bevacizumab maintenance every 21 days after initial treatment with bevacizumab 15 mg/kg, pemetrexed 500 mg/m², and carboplatin AUC 6 every 21 days for 6 cycles.
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Initial treatment with bevacizumab, pemetrexed, and carboplatin.
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Treatment-related grade 3/4 toxicities during initial treatment.
Number of subjects: 43
Study: 19240743

Group type: EXPERIMENTAL
Intervention: Real exposure to GSM signal from a mobile phone for 40 minutes
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham exposure (control)
Number of subjects: 11
Study: 18089866

Group type: EXPERIMENTAL
Intervention: RT plus PCV chemotherapy
Number of subjects: 368

Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 368
Study: 15333687

Group type: EXPERIMENTAL
Intervention: Tailored CPT-11 + S-1
Number of subjects: 0

Group type: COMPARATOR
Intervention: S-1
Number of subjects: 0
Study: 11696471

Group type: EXPERIMENTAL
Intervention: Warfarin therapy (group W)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Warfarin therapy (subject A)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Normal control group
Number of subjects: 9
Study: 10771920

Group type: EXPERIMENTAL
Intervention: Auditory brainstem responses in high risk neonates
Number of subjects: 50

Group type: COMPARATOR
Intervention: Auditory brainstem responses in normal neonates
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Follow-up at 6 months for high risk neonates
Number of subjects: 50